Statins ameliorate pulmonary hypertension secondary to left ventricular dysfunction through the Rho-kinase pathway and NADPH oxidase

NADPH Oxidases in Vascular Pathology

(2013) Anna Konior et al.   ANTIOXIDANTS & REDOX SIGNALING

Combination Therapy in Pulmonary Arterial Hypertension

(2013) Meredith E. Pugh et al.   CLINICS IN CHEST MEDICINE

Updated Clinical Classification of Pulmonary Hypertension

(2013) Gerald Simonneau et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Pulmonary arterial hypertension

(2013) David Montani et al.   Orphanet Journal of Rare Diseases

Targeted therapies in pulmonary arterial hypertension

(2013) David Montani et al.   PHARMACOLOGY & THERAPEUTICS

Reactive Oxygen Species and Antioxidants in Pulmonary Hypertension

(2012) Chi-Ming Wong et al.   ANTIOXIDANTS & REDOX SIGNALING

Reactive oxygen and nitrogen species in pulmonary hypertension

(2012) Diana M. Tabima et al.   FREE RADICAL BIOLOGY AND MEDICINE

Attenuation of Monocrotaline-induced Pulmonary Arterial Hypertension in Rats by Rosuvastatin

(2012) Xiao-Lin Li et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Nitric oxide synthase uncoupling: A therapeutic target in cardiovascular diseases

(2012) Nathan D. Roe et al.   VASCULAR PHARMACOLOGY

Recent development in the effects of statins on cardiovascular disease through Rac1 and NADPH oxidase

(2012) Jennifer M.F. Kwok et al.   VASCULAR PHARMACOLOGY

Rho-kinase: important new therapeutic target in cardiovascular diseases

(2011) Kimio Satoh et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Randomized Clinical Trial of Aspirin and Simvastatin for Pulmonary Arterial Hypertension

(2011) Steven M. Kawut et al.   CIRCULATION

The differential effect of statins on oxidative stress and endothelial function: Atorvastatin versus pravastatin

(2011) Jonathan R. Murrow et al.   Journal of Clinical Lipidology

Changes of Pulmonary Pathology and Gene Expressions After Simvastatin Treatment in the Monocrotaline-Induced Pulmonary Hypertension Rat Model

(2011) Yun Hee Lee et al.   Korean Circulation Journal

RhoA/Rho-kinase and vascular diseases: what is the link?

(2010) Kenia Pedrosa Nunes et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Bosentan does not improve pulmonary hypertension and lung remodeling in heart failure

(2010) B. H. Jiang et al.   EUROPEAN RESPIRATORY JOURNAL

Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil

(2010) K. T. B. Mouchaers et al.   EUROPEAN RESPIRATORY JOURNAL

Attenuation of pulmonary hypertension secondary to left ventricular dysfunction in the rat by Rho-kinase inhibitor fasudil

(2010) Zen-Kong Dai et al.   PEDIATRIC PULMONOLOGY

Novel pathway of endothelin-1 and reactive oxygen species in coronary vasospasm with endothelial dysfunction

(2009) Shu-Ichi Saitoh et al.   CORONARY ARTERY DISEASE

Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)

(2009) et al.   EUROPEAN HEART JOURNAL

Updated Clinical Classification of Pulmonary Hypertension

(2009) Gérald Simonneau et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Role of pravastatin in pulmonary hypertension in chronic obstructive pulmonary disease

(2008) Tamera J. Corte et al.   CLINICAL SCIENCE

Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension

(2008) Tsung-Ming Lee et al.   CLINICAL SCIENCE

Statins suppress MMP2 secretion via inactivation of RhoA/ROCK pathway in pulmonary vascular smooth muscles cells

(2008) Manxiang Li et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Endothelin-1 Regulates Cardiac L-Type Calcium Channels via NAD(P)H Oxidase-Derived Superoxide

(2008) Q. Zeng et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS